Drug Scientists Slow to Adopt Open Source

A surge in open-source technology has given many businesses more options for powerful, low-cost software. But the pharmaceutical industry remains well behind the curve.

This article was originally published on 09-08-2005
eWeek eWeek

Have the latest technology news and resources emailed to you everyday.